Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04763044 · ClinicalTrials.gov registry record · Phase 4
Evaluation of the Fluoride Dose Response Using In Situ Caries Model
A Phase 4 study, sponsored by Procter and Gamble.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT04763044 is a Phase 4 study that has completed, run by Procter and Gamble. The registered enrollment target is 15 participants.
The verdict
NCT04763044, a Phase 4 study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the fluoride dose response of different dentifrice fluoride concentrations - 0, 250, 1100 and 2800 ppm fluoride as sodium monofluorophosphate (MFP) and a fifth leg of 1100 ppm Stannous Fluoride (SnF2) using an in situ caries model.
Interventions
- DRUG 0 ppm F
- DRUG 250 ppm F as MFP
- DRUG 1100 ppm as MFP
- DRUG 2800 ppm F as MFP
- DRUG 1100 ppm SnF2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2021-07-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04763044
The ClinicalTrials.gov registry entry for NCT04763044 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which 0 ppm F is the first listed.
NCT04763044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04763044 about?
NCT04763044 is a clinical study titled "Evaluation of the Fluoride Dose Response Using In Situ Caries Model". The purpose of this study is to evaluate the fluoride dose response of different dentifrice fluoride concentrations - 0, 250, 1100 and 2800 ppm fluoride as sodium monofluorophosphate (MFP) and a fifth leg of 1100 ppm Stannous Fluoride (SnF2) using an in situ caries model.
What is the current status of trial NCT04763044?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2021-03-01. Estimated completion is 2021-07-21.
What interventions are being tested in trial NCT04763044?
The interventions under investigation include: 0 ppm F (DRUG), 250 ppm F as MFP (DRUG), 1100 ppm as MFP (DRUG), 2800 ppm F as MFP (DRUG), 1100 ppm SnF2 (DRUG).
Who is sponsoring clinical trial NCT04763044?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.